{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:14:14Z","timestamp":1753892054610,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>We report the case of a 54-year-old healthy Han Chinese male presenting with fever, pallor, erythematous subcutaneous nodules on the limbs, and significant anemia as indicated by routine blood tests, with no response to antimicrobial therapy. Initial skin biopsy was inconclusive. The erythematous subcutaneous nodules on the limbs rapidly progressed to widespread subcutaneous nodules across the body, with worsening anemia. Bone marrow biopsy revealed multifocal fibroblastic proliferation with focal fibrosis, classified as MF-2, and positive for the JAK2V617F mutation alongside SRSF2 positivity. Whole-body PET-CT scans did not reveal any lymph nodes or suspect lesions with high SUV uptake. A subsequent skin biopsy identified the condition as nodular panniculitis (NP), leading to a final diagnosis of primary myelofibrosis(PMF)with NP. The patient initially received treatment with oral ruxolitinib and prednisone acetate, resulting in normalization of body temperature, resolution of erythematous nodules, and normalization of blood parameters.<\/jats:p>","DOI":"10.3389\/fonc.2024.1412021","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T04:20:00Z","timestamp":1724041200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: A case of effective treatment of primary myelofibrosis with nodular panniculitis using ruxolitinib combined with corticosteroids"],"prefix":"10.3389","volume":"14","author":[{"given":"Guzailinuer","family":"Wufuer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainiwaer","family":"Babayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilinuer","family":"Abudureyimu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-hui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3760\/j:issn:1007-7480.2004.04.017","article-title":"Rheumatology Branch of Chinese Medical Association. Guidelines for diagnosis and treatment of nodular panniculitis","volume":"8","year":"2004","journal-title":"Chin J Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1442-200X.2006.02169.x","article-title":"Panniculitis in childhood and adolescence","volume":"48","author":"Moraes","year":"2006","journal-title":"Pediatr Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-7480.2009.01.036","article-title":"Clinical features and follow-up analysis of patients with panniculitis","volume":"13","author":"Lei","year":"2009","journal-title":"Chin J Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450213","article-title":"Skin manifestation of agnogenic myeloid metaplasia","volume":"45","author":"Loewy","year":"1994","journal-title":"Am J Hematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ajh.23539","article-title":"Cutaneous involvement by post-polycythemia vera myelofibrosis","volume":"89","author":"Pecci","year":"2014","journal-title":"Am J Hematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26050","article-title":"Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management","volume":"96","author":"Tefferi","year":"2021","journal-title":"Am J Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403804","article-title":"Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders","volume":"19","author":"Lichtman","year":"2005","journal-title":"Leukemia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.179.5.1791239","article-title":"Typical and atypical presentations of extramedullary hemopoiesis","volume":"179","author":"Georgiades","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4065\/78.10.1223","article-title":"Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment","volume":"78","author":"Koch","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2016.12.004","article-title":"Panniculitis: A summary","volume":"34","author":"Wick","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2016.12.004","article-title":"Progress in clinical research of panniculitis","volume":"14","author":"Liu","year":"2012","journal-title":"Southwest military doctor"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1989.tb00038.x","article-title":"Infection-induced panniculitis","volume":"16","author":"Patterson","year":"1989","journal-title":"J Cutan Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3881\/j.issn.1000-503X.2011.05.009","article-title":"Clinical and pathological analysis of 22 cases of lupus panniculitis","volume":"33","author":"Wang","year":"2011","journal-title":"J Chin Acad Med Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/JD9.0000000000000286","article-title":"Neutrophilic panniculitis associated with myelodysplastic syndrome\/myeloproliferative neoplasm: a case report\u00a0and literature review","volume":"6","author":"Cohen","year":"2023","journal-title":"Int J Dermatol Venereol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3760\/cma.j.issn.1673-4904.2011.33.037","article-title":"A case of myelodysplastic syndrome complicated with nodular panniculitis","volume":"34","author":"Gao","year":"2011","journal-title":"Chin J postgraduates Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232005","article-title":"Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia","volume":"12","author":"Fraticelli","year":"2019","journal-title":"BMJ\u00a0Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.969260","article-title":"Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis","volume":"56","author":"Jung","year":"2015","journal-title":"Leuk Lymphoma"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1412021\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T04:20:05Z","timestamp":1724041205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1412021\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":19,"alternative-id":["10.3389\/fonc.2024.1412021"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1412021","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"article-number":"1412021"}}